the aid library

MhGAP Child and adolescent mental and behavioural disorders, slides.
recommended

World Health Organization WHO (2010) C_WHO

mhGAP Training of Health-care Providers Training manual and Supporting material.

Atlas: country resources for neurological disorders 2004: results of a collaborative study of the World Health Organization and the World Federation of Neurology
recommended

World Health Organization; World Federation of Neurology (2004) C_WHO

NEUROLOGY ATLAS presents for the first time, the most comprehensive collection and compilation of information on neurological resources across 109 countries. The results confirm that the available resources including services for neurological disorders ... more

Role of anticholinergic medications in patients requiring long-term antipsychotic treatment for psychotic disorders

World Health Organization WHO (2012) C_WHO

Q6: In individuals with psychotic disorders (including schizophrenia) who require long term antipsychotic treatment, are anticholinergic medications more effective in preventing or reducing extrapyramidal side-effects and/or improving treatment adhe ... more

Comorbidity of substance use and mental health disorders in Europe

European Monitoring Centre for Drugs and Drug Addiction (2016) C2

Perspectives on drugs

CH 3: Psychosocial interventions, treatment of emotional disorders.

World Health Organization (2015) C_WHO

[Updated 2015] Scoping question: What is the effectiveness of psychosocial interventions, including caregiver skills training, for emotional disorders in children and adolescents?

Gender differences in the epidemiology of affective disorders and schizophrenia

Maco Piccinelli and Francesca Gomez Homen WHO (2000) C_WHO

This document seeks to enhance the attention of the people and governments of the world to the effects of mental health problems and substance abuse on the social well being and physical health of the world´s underserved population.

National Strategic Plan for Neurodevelopmental Disorders 2016-2021, Bangladesh
recommended

Institute for Community Inclusion UMass Boston; Suchona Foundation Ministry of Health and Family Welfare, Bangladesh (2016) C1

Burden of and Health Loss Due to the Effect of Maternal Hypertensive disorders in Ethiopia

Abebe, B.; Abera, M.; Sena, L. Ethiopian Journal of Health Development (2023) CC

Background: Worldwide, maternal hypertensive disorders complicate one in ten pregnancies. As a result of changes in the life styles of society, currently, it is becoming a common public life encounter. However, Ethiopia lacks comprehensive and compa ... rable maternal hypertensive disorders, causing burden and health loss to inform policy and practice. Objective: To describe the incidence and prevalence of maternal hypertensive disorders and deaths, Disability Adjusted Life Years, and Years Life Lost attributable to maternal hypertensive disorders in Ethiopia and its regional distributions from 1990 to 2019 as part of a collaborative Global Burden of Diseases, (2019) Study. Methods: The data for this study were collected from surveys, demographic surveillances, medical record reviews, health facility observations and interviews socio-demographic, health care service utilization, and other data sources such as case notifications, scientific literature, and unpublished data as per the Global Burden of Disease protocol and analysis techniques to produce national and regional estimates of maternal hypertensive disorders in Ethiopia. Cause of death ensemble modeling and Bayesian meta-regression disease modeling was employed to ascertain cause of death and morbidity. Each metric was estimated per 100,000 populations with a 95% uncertainty interval (UI). Results: In the last thirty years, in Ethiopia, , the incidence of maternal hypertensive disorders among young women was raised by 52,596 cases per 100,000 population [199,707 (95% UI 150,261-267,221) to 252,303 (95% UI 191,335-332,524)], while decreased among adolescent women from 67,206 (95% UI 46,887-90,883) to 64, 622 (95% UI; 47,587-84,664) per 100,000 population. The prevalence among women of reproductive age had increased from 94, 818 (95% UI 59,434-135,332) in 1990 to 138, 263 (95% UI 88,447-196,029) in 2019. Between 1990 and 2019, deaths attributable to maternal hypertensive disorders among adolescents and young women had increased by 1.5 and 1.17 times, respectively. In 2019, disability adjusted life years among adolescent, young women and women of reproductive age due to maternal hypertensive disorders was 8,493 (UI 95% 5,370-12,849), 21,812 (UI 95% 14,682-32,139) and 57,867 (UI 95% 41,751-79,165) respectively. The highest daily adjusted life years due to maternal hypertensive disorders had occurred among young women, 13,319 (UI 95% 8,592-19,931) which was higher than 1990 whereas the young women years of life lost had increased. Conclusions: Based on the finding, increasingly high new cases, prevalence and burden of maternal hypertensive disorders and significant health loss were observed in the last three decades in Ethiopia. Hence, prevention of cases, disabilities, deaths and health losses caused by maternal hypertensive disorders can be prevented by properly advocating lifestyle modifications with specifically designed age-specific interventions. On the top of continuing prevention efforts with newly devised magnesium sulphate administration in the new ANC initiative of the ministry, contextualized, need based, localized, and targeted interventions could be reconstituted. [Ethiop. J. Health Dev. 2023;37 (SI-2)] more

Clinical Practice Guideline for Treatment of Patients with Anxiety Disorders in Primary Care

Ministry of Health and Consumer Affairs, Agencia Laín Entralgo. Unidad de Evaluación de Tecnologías Sanitaria, Madrid (2010) C2

The purpose of the Clinical Practice Guideline for Treatment of Patients with Anxiety Disorders in Primary Care is to provide professionals with practical recommendations based on scientific evidence to assist in the detection and effective treatmen ... more

CH 1: Caregiver skills training for the management of developmental disorders

World Health Organization (2015) C_WHO

(Updated 2015) Scoping question: What is the effectiveness of caregiver skills training in the management of children and adolescents with developmental disorders?

International standards for the treatment of drug use disorders - Revised Edition Incorporating Results Of Field - Testing

World Health Organization WHO (2020) C_WHO

This document is based on currently available scientific evidence on treatment for drug use disorders and sets out a framework for the implementation of the Standards, in line with principles of public health care. The Standards identify major compo ... more

Evidence-Based Guidelines for Mental, Neurological, and Substance Use Disorders in Low- and Middle-Income Countries: Summary of WHO Recommendations.

Dua T, Barbui C, Clark N, Fleischmann A, Poznyak V, et al. PLoS Medicine (2011) CC

PLoS Med 8(11): e1001122. doi:10.1371/journal.pmed.1001122

Module: MhGAP Child and adolescent mental and behavioural disorders.
recommended

World Health Organization WHO WHO (2010) C_WHO

Overview Learning objectives • Promote respect and dignity for children and adolescents with mental and behavioural disorders. • Know common presentations of children and adolescents with mental and behavioural ... more

Cross-Cultural Examination of Knowledge and Beliefs about Mental Disorders

Altweck, L. (2016) C2

Dissertationsubmitted for the degree of Doctor of Philosophy, Brunel University

Prevention of Drug Use and Treatment of Drug Use Disorders in Rural Settings
recommended

United Nations Office on Drug and Crime UNODC (2017) C1

Improving access to care for children with mental disorders: A global perspective

V. Patel; C. Kieling; P. K. Maulik; G. Divan Europe PMC Funders Group (2013) C2

Europe PMC Funders Group Author Manuscript Arch Dis Child. Author manuscript; available in PMC 2013 November 01. Published in final edited form as: Arch Dis Child. 2013 May ; 98(5): 323–327. doi:10.1136/archdischild-2012-302079.

mhGAP Training Manuals - for the mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings, version 2.0
recommended

World Health Organization WHO WHO (2017) C_WHO

As part of the Mental Health Gap Action Programme, WHO has developed training manuals (Training of trainers and supervisors training manual and Training of health-care providers training manual) to support implementation of the mhGAP Intervention Guide for mental, neurological and substance use (MNS ... more

B1 Perinatal and early childhood risk and protective factor and disorders: early maltreatment and exposure to violence

Susan MK Tan, Norazlin Kamal Nor, Loh Sit Fong, Suzaily Wahab, Sheila Marimuthu & Chan Lai Fong IACAPAP (2015) C1

This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o ... more

Urban social stress e Risk factor for mental disorders. The case of schizophrenia

Florian Lederbogen, Leila Haddad, Andreas Meyer-Lindenberg (2013) C2

Environmental Pollution http://dx.doi.org/10.1016/j.envpol.2013.05.046